Wendy Stock

27PUBLICATIONS

233CO-AUTHORS

Haematological tumoursGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Adolescent health

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (27)

Sort by Publication Date:

|Jun 15, 2026

Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia.

|Apr 17, 2026

Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic Leukemia.

|Mar 04, 2026

Targeting menin in T-lineage acute lymphoblastic leukemia.

Kathryn Shimamoto, Diren Arda Karaoglu, Olivia Arnold

|Sep 30, 2025

Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results.

Matthew J Wieduwilt, Jun Yin, Oudom Kour

|Aug 14, 2025

Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults.

Ethan J Harris, Diren Arda Karaoglu, Madina Sukhanova

|Jun 12, 2025

Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed <i>NPM1</i>-Mutated or <i>KMT2A</i>-Rearranged AML.

Joshua F Zeidner, Tara L Lin, Rina Li Welkie

Pageof 5

Frequent Collaborators

Adam S DuVall

Geoffrey L Uy

Caner Saygin

Ann-Kathrin Eisfeld

Anand Ashwin Patel

Richard M Stone

Charles G Mullighan

Olatoyosi Odenike

Alice S Mims

Selina M Luger

Frequent Collaborators

Adam S DuVall

Geoffrey L Uy

Caner Saygin

Ann-Kathrin Eisfeld